ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings
  • Abstract Number: 53 • 2018 ACR/ARHP Annual Meeting

    Cyclin-Dependent Kinase 4/6 Inhibitor: A Promising Development Candidate Targeting Synovial Hypertrophy for Rheumatoid Arthritis Treatment

    Shunsuke Tsujimoto, Kyohei Horie, Toshiya Mashiko, Johji Nomura and Tsunefumi Kobayashi, Teijin Institute for Bio-medical Research, TEIJIN PHARMA LIMITED, Tokyo, Japan

    Background/Purpose: The pathogenesis of rheumatoid arthritis (RA) is characterized by the infiltration of immune cells into the synovial tissues and the hypertrophy of synovial fibroblasts,…
  • Abstract Number: 54 • 2018 ACR/ARHP Annual Meeting

    In a Macaque Model of RA By Immunization with Citrullinated Peptides, the Valine in the 11 Position of the DRB1 Molecule Has Greater Impacts on T-Cell Response to Citrullinated Peptides Than the 70-74 Position in the Shared Epitope

    Samuel Bitoun1, Pierre Roques2, Roger Le Grand3 and Xavier Mariette4, 1INSERM U1184, IMVA, Paris Sud University,LabEx LERMIT, Le Kremlin Bicêtre, France, 2Immunology of viral infections and autoimmune diseases, IDMIT Infrastructure CEA - Université Paris Sud - INSERM U1184, Fontenay-Aux-Roses,, France, 3Immunology of viral infections and autoimmune diseases, IDMIT Infrastructure CEA - Université Paris Sud - INSERM U1184, Fontenay-Aux-Roses, France, 4Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France

    Background/Purpose: Among genetic risk factors of RA, HLA class II molecules confers the highest risk of ACPA positive RA. The shared epitope (SE) hypothesis that…
  • Abstract Number: 55 • 2018 ACR/ARHP Annual Meeting

    Adipose Derived Stem Cell Suppressed Synovial Inflammation and Repaired Cartilage Destruction in Rheumatoid Arthritis Model Mice

    Tadashi Okano1, Kentaro Inui2, Hideki Ueyama3, Kumi Orita3, Tatsuya Koike4 and Hiroaki Nakamura2, 1Orthopedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 2Orthopaedic Surgery, Osaka City University Graduate School of Medicine, Osaka, Japan, 3Osaka City University Graduate School of Medicine, Osaka, Japan, 4Center for Senile Degenerative Disorders, Osaka City University Graduate School of Medicine, Osaka, Japan

    Background/Purpose: Adipose derived stem cell (ADSC) is one of the stem cells produced by adipose tissue which can be collected easily and in large quantities.…
  • Abstract Number: 56 • 2018 ACR/ARHP Annual Meeting

    Comparison of Metabolic Changes in Osteoarthritis and Rheumatoid Arthritis Mouse Models

    Marie-Lisa Hülser1, Hani Manfred Sauermilch1, Carina Schreiyäck1, Yubin Luo2, Aline Bozec2, Georg Schett3, Ulf Müller-Ladner4 and Elena Neumann1, 1Dept. of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Gießen, Germany, Bad Nauheim, Germany, 2University of Erlangen-Nürnberg, Department Clinic of Medicine 3 - Immunology and Rheumatology, Erlangen, Germany, Erlangen, Germany, 3Friedrich-Alexander-Universität Erlangen, Nürnberg und Universitätsklinikum Erlangen, Erlangen, Germany, 4Dept. of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus-Liebig-University Giessen, Germany, Bad Nauheim, Germany

    Background/Purpose: Adipocytokines are bioactive factors produced mainly by adipose tissue. They not only regulate energy homeostasis, but also influence immune responses. Osteoarthritis (OA) is one…
  • Abstract Number: 57 • 2018 ACR/ARHP Annual Meeting

    Repository Corticotropin Injection (H.P. Acthar® Gel) Inhibits Bone Degradation in Rat Adjuvant-Induced Arthritis Model

    Dale Wright, Ben Zweifel, Steve Settle and Rick Fitch, Pharmacology, Mallinckrodt Pharmaceuticals, Hazelwood, MO

    Background/Purpose: Repository corticotropin injection (RCI: H.P. Acthar® gel) contains a purified porcine pituitary ACTH-analogue, and is an FDA-approved treatment for short-term adjunctive therapy of acute…
  • Abstract Number: 58 • 2018 ACR/ARHP Annual Meeting

    Inhibition of Lipid Phosphatase SHIP1 Expands Myeloid-Derived Suppressor Cells and Attenuates Rheumatoid Arthritis in Mice

    Eui Young So1, Changqi Sun2, Patrycja M Dubielecka1, Anthony M. Reginato3 and Olin D. Liang1, 1Division of Hematology/Oncology, Rhode Island Hospital, Providence, RI, 2Division of Rheumatology, Rhode Island Hosital/The Warren Alpert School of Medicine of Brown University, Providence, RI, 3Division of Rheumatology, Rhode Island Hospital, Providence, RI

    Background/Purpose: The SH2-containing inositol-5’-phosphatase-1 (SHIP1) controls PI3K initiated signaling by limiting membrane recruitment and activation of AKT. SHIP1 knockout in mice leads to an increase…
  • Abstract Number: 59 • 2018 ACR/ARHP Annual Meeting

    Elucidating the Expression and Role of Heparan Sulfate Proteoglycan Editing Sulfatases in Human Rheumatoid Arthritis Synovium and a Rat Adjuvant-Induced Arthritis Model

    Ruby J. Siegel1, Solomon A. Agere1, Anil K. Singh1 and Salahuddin Ahmed2,3, 1Washington State University, Department of Pharmaceutical Sciences, College of Pharmacy, Spokane, WA, 2Department of Pharmaceutical Sciences, Washington State University, College of Pharmacy, Spokane, WA, 3Division of Rheumatology, University of Washington, Division of Rheumatology, School of Medicine, Seattle, WA

    Background/Purpose: Syndecans are cell-surface heparan sulfate proteoglycans (HSPGs) that modulate the receptor/ligand binding of chemokines, cytokines, and growth factors in order to facilitate cellular signaling.…
  • Abstract Number: 60 • 2018 ACR/ARHP Annual Meeting

    Combined Inhibition of Mechanistic Target of Rapamycin and Glutamine Metabolism Inhibits CD4 T Cell Proliferation and Th17 Differentiation, Facilitates the Expansion of Myeloid-Derived Suppressor Cells, and Synergistically Ameliorates Arthritis in SKG Mice

    Yo Ueda1, Jun Saegusa1, Tadashi Okano2, Sho Sendo1, Hirotaka Yamada2, Kengo Akashi1, Akira Onishi1 and Akio Morinobu1, 1Rheumatology and Clinical Immunology, Kobe University Graduate School of Medicine, Kobe, Japan, 2Rheumatology and Clinical immunology, Kobe University Graduate School of Medicine, Kobe, Japan

    Background/Purpose: The mechanistic target of rapamycin (mTOR) pathway and glutamine metabolism are activated cooperatively in the differentiation and the activation of inflammatory immune cells such…
  • Abstract Number: 61 • 2018 ACR/ARHP Annual Meeting

    A Human ACPA Monoclonal Antibody Is Preferably Localized at Inflammatory Gingival Tissue and Activates Osteoclastogenensis in Porphyromonas Gingivalis Infected SKG Mouse

    Kazuhisa Ouhara1, Tatsuhiko Ozawa2, Syuichi Munnaga1, Tatsuomi Kuranobu3, Yuta Hamamoto1, Toshihisa Kawai4, Eiji Sugiyama5 and Hidemi Kurihara1, 1Periodontal Medicine, Hiroshima University, Hiroshima, Japan, 2Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama, Japan, 3Clinical Immunology and Rheumatology, HIroshima University Hospital, Hiroshima, Japan, 4Periodontology, Nova Southeastern University College of Dental Medicine, Fort Lauderdale, FL, 5Department of Clinical Immunology and Rheumatology, Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan

    Background/Purpose: Periodontal disease (PD) is the chronic inflammatory disease caused by the infection of periodontopathogenic bacteria, Porphyromonas gingivalis (Pg). Pg infection is known as major…
  • Abstract Number: 62 • 2018 ACR/ARHP Annual Meeting

    CCR6+CD4+ T Cells Drive IL-23R Signaling-Dependent Progression of Antigen-Induced Arthritis

    W Razawy1, N Salioska2, P Asmawidjaja3, A Otten-Mus4, N Kops5, M Oukka6, V Kuchroo7 and Erik Lubberts3, 1Rheumatology and Immunology, Erasmus MC, Rotterdam, Netherlands, 2Rheumatology, Erasmus MC, Rotterdam, Netherlands, 3Rheumatology and Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 4Immunology, Erasmus MC, University Medical Center, Rotterdam, Netherlands, 5Orthopedics, Erasmus MC, Rotterdam, Netherlands, 6Pediatrics, Seattle Children's Research Institute, Seattle, WA, 7Center for Neurologic Diseases, Harvard Institute of Medicine, Boston, MA

    Background/Purpose: The IL-23/IL-17A immune pathway is important for the progression of T cell-mediated arthritis. However, it is not known where IL-23R+ T cells locate during…
  • Abstract Number: 63 • 2018 ACR/ARHP Annual Meeting

    TNF-α Blockade Incompletely Reverses Inflammatory Pulmonary Pathology in the TNF-Transgenic Mouse Model of Rheumatoid Arthritis

    Emily Wu1, Richard Bell2, Edward Schwarz3 and Homaira Rahimi4, 1Department of Immunology, Microbiology, and Virology, University of Rochester, Rochester, NY, 2Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 3Orthopedeatrics, University of Rochester, Rochester, NY, 4Rheumatology, University of Rochester/Golisano Children's Hosp, Rochester, NY

    Background/Purpose: Interstitial lung disease (ILD) is a significant contributor to rheumatoid arthritis (RA) mortality, yet its pathogenesis remains enigmatic. One theory posits that initial inflammatory…
  • Abstract Number: 64 • 2018 ACR/ARHP Annual Meeting

    Dietary Magnesium Modulates the Intestinal Microbiome and T Cell Subsets

    Teresina Laragione1, Carolyn Harris1 and Percio S. Gulko2, 1Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Several studies have demonstrated that Magnesium (Mg) has a key role in the immune responses. Our previous studies showed that a short-term low Mg…
  • Abstract Number: 65 • 2018 ACR/ARHP Annual Meeting

    Bacteria-Derived Indole Drives Autoimmune Arthritis By Altering B Cell Glycosylation of Autoantibodies

    Widian Jubair1, Erica Alexeev2, Timothy Lemke3, Meagan Chriswell1, Sean Colgan2 and Kristine A Kuhn1,2, 1Rheumatology, University of Colorado Denver, Aurora, CO, 2Mucosal Inflammation Program, University of Colorado Denver, Aurora, CO, 3University of Colorado Denver, Aurora, CO

    Background/Purpose: Ongoing studies in rheumatoid arthritis (RA) implicate intestinal dysbiosis of bacteria as a contributing factor, though the mechanism(s) by which bacteria influence disease is…
  • Abstract Number: 66 • 2018 ACR/ARHP Annual Meeting

    Suppression of Inflammatory Arthritis, in Human Paraoxonase 1 Transgenic Mice, Correlates with Upregulation of the Hepatic Glutathione Pathway and Reduction of Bioactive Lipid Mediators

    Christina Charles-Schoeman1, Ani Shahbazian2, Jennifer Wang3, Xiaoyan Wang2, Ernest Brahn2, Jeremy Papesh2, Victor Grijalva4 and Srinivasa T. Reddy2, 1Rheumatology, UCLA David Geffen School of Medicine, Los Angeles, CA, 2University of California, Los Angeles, Los Angeles, CA, 3University of California Los Angeles, Los Angeles, CA, 4Medicine-Cardiology, University of California, Los Angeles, Los Angeles, CA

    Background/Purpose: Paraoxonase 1 (PON1) is an HDL-associated protein, which hydrolyzes biologically active oxidized phospholipids and prevents oxidation of lipids in LDL and HDL. Increased lipid…
  • Abstract Number: 67 • 2018 ACR/ARHP Annual Meeting

    Intestinal Inflammation and Netosis Associate with the Presence of Stool IgA ACPA in Subjects at-Risk for RA

    Widian Jubair1, Elizabeth A. Bemis2, Yuko Okamoto3, Marie L. Feser3, Jennifer Seifert3, M. Kristen Demoruelle3, Jill M. Norris4, Kevin D. Deane3, V. Michael Holers5 and Kristine A Kuhn1,6, 1Rheumatology, University of Colorado Denver, Aurora, CO, 2Epidemiology, Colorado School of Public Health, Aurora, CO, 3Division of Rheumatology, University of Colorado Denver, Aurora, CO, 4Department of Epidemiology, Colorado School of Public Health, Aurora, CO, 5Rheumatology Division, University of Colorado Denver, Aurora, CO, 6Mucosal Inflammation Program, University of Colorado Denver, Aurora, CO

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) and inflammation characterized by neutrophil extracellular trap (NET)osis have been detected at mucosal sites such as the lung and periodontium…
  • « Previous Page
  • 1
  • …
  • 1188
  • 1189
  • 1190
  • 1191
  • 1192
  • …
  • 2607
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology